Cytology of Human Ovarian Surface Epithelial Brushings

Cancer

Volumn 102, Issue 1, 2004, Pages 1-10

  Nicosia, Santo V ^a,b   Wilbanks, George D ^a   Saunders, Beatriz ^a   Mayer, James ^a   Cardosi, Richard J ^a   Kruk, Patricia A ^a   Cheng, Jin ^a   Bai, Wenlong ^a   Coppola, Domenico ^a   Fiorica, James ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cell yield; Cytology; Human ovarian surface epithelium; Nucleic acid protein content; Ovarian brushings

Indexed keywords

CELL NUCLEUS DNA; CYTOKERATIN; NUCLEAR PROTEIN; PROTEIN P53; RNA; VIMENTIN;

ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER RISK; CELL DENSITY; CELL POPULATION; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; EPITHELIUM CELL; FEMALE; FEMALE INFERTILITY; GYNECOLOGIC DISEASE; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LAPAROSCOPY; LAPAROTOMY; MENSTRUAL CYCLE; MONOLAYER CULTURE; NUCLEOLUS; OVARY CANCER; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BIOPSY, NEEDLE; COHORT STUDIES; CYTODIAGNOSIS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; LAPAROTOMY; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN DISEASES; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 10744229481     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20001     Document Type: Article

References (52)

1. Jernal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
2. Nicosia SV, Nicosia RF. Neoplasms of the ovarian mesothelium. In: Hazar HA, editor. Pathology of human neoplasms. New York: Raven Press, 1988:435-486.
3. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology and pathology. Endocr Rev. 2001;22:255-288.
4. Pharoah PD, Easton DF, Stockton DL, Gayther S, Ponder BA. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. Cancer Res. 1999;59:868-871.
5. Lewis S, Menon U: Screening for ovarian cancer. Expert Rev Anticancer Ther. 2003;3:55-62.
6. Lounis H, Provencher D, Godbout C, Fink D, Milot MJ, Mes-Masson AM. Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies. Exp Cell Res. 1994;215:303-309.
7. Nakamura M, Katabuchi H, Ohba T, Fukumatsu Y, Okamura H. Isolation, growth and characteristics of human ovarian surface epithelium. Virchows Arch. 1994;424:59-67.
8. Ismail RS, Baldwin RL, Fang J, et al. Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res. 2000;60:6744-6749.
9. Graham RM. The cytologic diagnosis of cancer. Philadelphia: Saunders, 1972.
10. Gillett WR, Mitchell A, Hurst PR. A scanning electron microscopic study of the human ovarian surface epithelium: characterization of two cell types. Hum Reprod. 1991;6:645-650.
11. Hafez ES, Makabe S. Surface ultrastructure of polycystic ovaries as viewed by electron microscopy. Acta Eur Fertil. 1979;10:119-129.
12. Salazar H, Godwin AK, Daly MB, et al. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst. 1996;88:1810-1820.
13. Resta L, Scordari MD, Colucci GA, et al. Morphological changes of the ovarian surface epithelium in women with ovarian polycystic disease or endometrial carcinoma as a control group. Eur J Obstet Gynaecol Oncol. 1989;10:39-41.
14. Tressera F, Grases PJ, Labastida R, Ubeda A. Histological features of the contralateral ovary in patients with unilateral ovarian cancer: a case control study. Gynecol Oncol. 1998;71:437-441.
15. Nicosia SV, Ku NN, Oliveros-Saunders B, et al. Ovarian mesothelium (surface epithelium) in normal, pathological and experimental conditions. In: Motta PM, editor. Recent advances in microscopy of cells, tissues and organs. Rome: Delfino, 1997:509-517.
16. Altman PL, Katz DD. Cell biology. Bethesda: Federation for Experimental Biology, 1976:363-386.
17. Nicosia SV. Ovarian changes during the climacteric. In: Mastroianni L, Paulsen AC, editors. Aging, reproduction and the climacteric. New York: Plenum Publishing, 1986:179-199.
18. Blaustein A. Surface cells of the ovary and pelvic peritoneum: a histochemical and ultrastructure comparison. Gynecol Oncol. 1979;8:34-43.
19. Okamura H, Katabuchi H. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability. Ital J Anat Embryol. 2001;106(2 Suppl 2):263-276.
20. Fox H. Pathology of early malignant change in the ovary. Int J Gynecol Pathol. 1993;12:153-155.
21. Nicosia SV, Saunders BO. Initial characterization of a luteal growth factor for ovarian mesothelial cells. In: Hirshfield AN, editor. Growth factors and the ovary. New York: Plenum Publishing, 1989:237-244.
22. Syed V, Ulinski G, Mok SC, Yiu GK, Ho SM. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res. 2001;61:6768-6776.
23. Osterholzer HO, Streibel EJ, Nicosia SV. Growth effects of protein hormones on cultured rabbit ovarian mesothelial cells. Biol Reprod. 1985;33:247-258.
24. Ivarsson K, Sundfelt K, Brannstrom M, Hellberg P, Janson PO. Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells. Hum Reprod. 2001;16:18-23.
25. Armuth V, Berenblum I. Mechanism of ovarian carcinogenesis: effect of 7,12-dimethylbenz[a]anthracene administration on intrasplenic ovarian grafts in unilaterally ovariectomized C3HeB/Fe mice. J Natl Cancer Inst. 1979;63:1047-1050.
26. Sushan A, Paltiel O, Schenker JG. Induction of ovulation and borderline ovarian cancer-the hormonal connection? Eur J Obstet Gynecol Reprod Biol. 1999;85:71-74.
27. Purdie DM, Bain CJ, Siskind V, Webb PM, Green AC. Ovulation and risk of epithelial ovarian cancer. Int J Cancer. 2003;104:228-232.
28. Garg PP, Kerlikowske K, Subak L, Grady D. Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol. 1998;92:472-479.
29. Coughlin SS, Giustozzi A, Smith SJ, Lee NC. A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. J Clin Epidemiol. 2000;53:367-375.
30. Lacey JV, Mink PJ, Lubin JH, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002;288:334-341.
31. Scully R. Pathology of ovarian cancer precursors. J Cell Biochem Suppl. 1995;23:208-218.
32. Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol. 1999;72:437-442.
33. Singer G, Kurman RJ, Chang HW, Cho SK, Shih IM. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol. 2002;160:1223-1228.
34. Gusberg SD, Deligdish L. Ovarian dysplasia: a study of identical twins. Cancer. 1984;54:1-4.
35. Deligdish L, Einstein AI, Guera D, Gil J. Ovarian dysplasia in epithelial inclusion cysts. Cancer. 1995;76:1027-1033.
36. Resta L, Russo S, Colucci GA, Prat J. Morphologic precursors of ovarian epithelial tumors. Obstet Gynecol. 1993;82:181-186.
37. Werness BA, Afify AM, Bielat KL, Elatbbakh GH, Piver MS, Paterson JM. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum Pathol. 1999;30:151-157.
38. Werness BA, Afify AM, Eltabbakh GH, Huelsman K, Piver MS, Paterson JM. p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer. Int J Gynecol Pathol. 1999;18:338-343.
39. Mittal KR, Zeleniuch-Jacquotte A, Cooper JL, Demopoulos RI. Contralateral ovary in unilateral carcinoma: a search for preneoplastic lesions. Int J Gynecol Pathol. 1993;12:59-63.
40. Sherman ME, Lee JS, Burks RT, Struewing JP, Kurman RJ, Hartge P. Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis. Int J Gynecol Pathol. 1999;18:151-157.
41. Stratton JF, Buckley H, Lowe D, Ponder BA. Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. J Natl Cancer Inst. 1999;91:626-628.
42. Barakat RR, Federici MG, Saigo PE, Robson ME, Offit K, Boyd J. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer. 2000;89:383-390.
43. Connolly DC, Bao R, Nikitin AY, et al. Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res. 2003;63:1389-1397.
44. Bandera CA, Ye B, Mok SC. New technologies for the identification of markers for early detection of ovarian cancer. Curr Opin Obstet Gynecol. 2003;15:51-55.
45. Hoskins WJ. Prospective on ovarian cancer: why prevent? J Cell Biochem Suppl. 1995;23:189-199.
46. Nagele F, Sator MO, Juza J, Huber JC. Successful pregnancy resulting from in-vitro matured oocytes retrieved at laparoscopic surgery in a patient with polycystic ovary syndrome: case report. Hum Reprod. 2002;17:373-374.
47. Gillett WR. Artefactual loss of human ovarian surface epithelium: potential clinical significance. Reprod Fertil Dev. 1991;3:93-98.
48. Luesley DM, Williams DR, Ward K, Redman CR, Lawton FG. Prospective comparative cytologic study of direct peritoneal smears and lavage fluids in patients with epithelial ovarian cancer and benign gynecologic disease. Acta Cytol. 1990;34:539-544.
49. Bateman BG, Kolp LA, Hoeger K. Complications of laparoscopy-operative and diagnostic. Fertil Steril. 1996;66:30-35.
50. Kaaijk EM, Beek JF, van der Veen F. Laparoscopic surgery of chronic hyperandrogenic anovulation. Lasers Surg Med. 1995;16:292-302.
51. Kruk PA, Maines-Bandiera SL, Auersperg N. A simplified method to culture human ovarian surface epithelium. Lab Invest. 1990;63:132-136.
52. Nicosia SV, Mayer J, Muro-Cacho C, et al. Harvesting of ovarian mesothelium [abstract]. Acta Cytol. 1997;41:1628a.